Yousif Capital Management, LLC I Teos Therapeutics, Inc. Transaction History

Yousif Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 30, 2023	SELL	$10.95 - $14.6 $164 - $219	-15 Reduced 0.07%	21,143 $231,000
Q2 2023 Aug 02, 2023	SELL	$12.93 - $18.05 $11,818 - $16,497	-914 Reduced 4.14%	21,158 $280,000
Q1 2023 May 02, 2023	SELL	$13.02 - $22.62 $27,732 - $48,180	-2,130 Reduced 8.8%	22,072 $300,000
Q4 2022 Jan 09, 2023	BUY	$17.77 - $21.6 $34,029 - $41,364	1,915 Added 8.59%	24,202 $0
Q3 2022 Nov 04, 2022	BUY	$18.6 - $27.25 $50,368 - $73,793	2,708 Added 13.83%	22,287 $425,000
Q2 2022 Aug 01, 2022	BUY	$16.57 - $35.1 $11,847 - $25,096	715 Added 3.79%	19,579 $403,000
Q1 2022 May 12, 2022	BUY	$31.92 - $47.45 $602,138 - $895,096	18,864 New	18,864 $607,000

166

36.6M

1.95M

374K

Ticker ITOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,575,300
Market Cap $257M
Description
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...

Get notified when there are updates to the investment portfolio of Yousif Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Yousif Capital Management, LLC with notifications on news.